Want to join the conversation?
Citigroup analyst Liav Abraham probed on the pricing dynamics in the legacy Par business. $ENDP said that pricing pressure in the legacy Par business may be in low single digit, but for the most part it is flat. The company said that it was able to defend that business because of less competition.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?